BREAST DISEASE DIAGNOSIS AND THERAPY MARKETS: EUROPE AND ASIA-PACIFIC

241 Pages | 95 Exhibits | 2009 Analysis | Forecasts Through 2014 Product Family: Market Reports




OVERVIEW:
The market for breast cancer detection, diagnosis, and treatment is well-developed in the U.S. and much of Europe. It has remained relatively under-developed in the Asia-Pacific region, however, although recent trends suggest that the opportunities for device manufacturers are improving, driven by the growing prevalence of breast disease in these countries.

In the U.S. and Europe, mammography is the standard of care for the early detection of breast cancer. Broader adoption is expected in the Asia-Pacific region, however, which will contribute to higher rates of detection. Outside of the U.S., the vast majority of ultrasound and magnetic resonance imaging (MRI) systems are used for general radiology and are not dedicated specifically to imaging the breast. The ability of these systems to differentiate between tissue types that cannot be distinguished by mammography should contribute to incremental sales in Europe and the Asia-Pacific region. Higher rates of detection resulting from the broader adoption of imaging systems should contribute to sales of biopsy devices, which are used to confirm the presence of breast cancer.

This report covers the market for the detection, diagnosis, and treatment of breast disease in selected countries in Europe and the Asia-Pacific region through 2014, and provides an in-depth analysis of the economic and clinical factors driving sales of mammography, ultrasound, MRI and contrast-enhanced imaging products, and interventional devices.

TABLE OF CONTENTS:
1. EXECUTIVE SUMMARY	
1.1	Clinical Background and Statistics	
1.2	Factors Affecting the Market for Breast Cancer	
1.3	Product Markets	
	1.3.1	Mammography	
	1.3.2	Ultrasound
		1.3.2.1	Challenges to the Adoption of Ultrasound	
		1.3.2.2	MRI & Contrast-Enhanced Imaging
	1.3.3	Interventional Procedures	
1.4	Procedure and Market Forecasts	

Exhibit 1-1: Global Rates of Incidence and Survival for Breast Cancer 
Exhibit 1-2: Global Economic Statistics 
Exhibit 1-3: Mammography Procedure Forecast by Region, 2008-2014 
Exhibit 1-4: Ultrasound Procedure Forecast by Region, 2008-2014 
Exhibit 1-5: MRI Procedure Forecast by Region, 2008-2014 
Exhibit 1-6: Biopsy Procedure Forecast by Region, 2008-2014 
Exhibit 1-7: Breast Diag. & Ther. Device Sales in Europe, 2008-2014 
Exhibit 1-8: Breast Diag. & Ther. Device Sales in Asia-Pacific, 2008-2014	

2.	BREAST DISEASE - BACKGROUND AND STATISTICS	
2.1	Breast Anatomy	
2.2	Malignant Breast Disease	
	2.2.1	Invasive Breast Cancer	
	2.2.2	Ductal Carcinoma in situ	
	2.2.3	Atyp. Ductal Hyperplasia/Atyp. Lobular Hyperplasia	
	2.2.4	Tumor Staging	
2.3	Risk Factors:  Breast Cancer	
2.4	Disease Prevalence and Forecasts	
2.5	Benign Breast Disease
	2.5.1	Fibroadenoma	
	2.5.2	Cyst	
	2.5.3	Fibrocystic Disease	
	2.5.4	Benign Papilloma	
2.6	Summary	

Exhibit 2-1: Breast Anatomy and Malignant Disease States
Exhibit 2-2: Inconsistency in DCIS/ADH Diagnosis
Exhibit 2-3: Breast Cancer Staging and Survivability 
Exhibit 2-4: Breast Cancer Staging and Treatment Options 
Exhibit 2-5: Worldwide Distribution of Breast Cancer 
Exhibit 2-6: Breast Cancer Diagnosis & Mortality, Trends & Forecasts	

3.	REGIONAL FACTORS AFFECTING BREAST CANCER MORTALITY	
3.1	Regional Factors Affecting Breast Cancer Mortality	
3.2	Economics, Screening, Incidence, and Lifestyle	
3.3	Healthcare Payment: Public vs. Private	
3.4	Distribution	
3.5	Geopolitical Regions	
	3.5.1	Europe	
		3.5.1.1	France	
		3.5.1.2	Germany	
		3.5.1.3	United Kingdom	
		3.5.1.4	Scandinavian Countries	
		3.5.1.5	Other Countries, Northern/Western Europe	
		3.5.1.6	Countries in Southern/Western Europe	
		3.5.1.7	Countries of the Former Soviet Union	
	3.5.2	Asia-Pacific	
		3.5.2.1	China	
		3.5.2.2	India	
		3.5.2.3	Japan	
		3.5.2.4	Australia/New Zealand	
		3.5.2.5	Rest of Asia	

Exhibit 3-1: Severity of Cancer: Diagnosis, Mortality, and Early Detection 
Exhibit 3-2: European Regions Covered in this Report 
Exhibit 3-3: European Population Forecast, 2008 to 2014 
Exhibit 3-4: Relevant Economic Statistics in Europe 
Exhibit 3-5: Rates of Incidence and Survival for Breast Cancer in Europe 
Exhibit 3-6: Mammography Frequency and Compliance in Europe 
Exhibit 3-7: Hospital Beds per 1,000,000 Population in Europe, 1996-2014 
Exhibit 3-8: Countries Included in the Asia-Pacific Region 
Exhibit 3-9: Insured and Uninsured Populations in China 
Exhibit 3-10: Population Forecasts for Asia-Pacific Countries, 2008-2014 
Exhibit 3-11: Economic Demographics in the Asia-Pacific Region 
Exhibit 3-12: Millionaires in Different Countries and Regions During 2008 
Exhibit 3-13: Breast Cancer Screening in the Asia-Pacific Region in 2008 
Exhibit 3-14: Number of Hospitals in India and the U.S.	

4.	MAMMOGRAPHY	
4.1	Devices Costs	
4.2	Screening and Diagnostic Mammography	
4.3	Mammography Process	
	4.3.1	Image Acquisition	
	4.3.2	Detection (Screening) vs. Diagnosis	
	4.3.3	Certifications for Radiologists	
	4.3.4	Viewing the Images	
	4.3.5	Diagnostic Exam	
4.4	Reimbursement	
4.5	Product Offerings	
	4.5.1	Image Acquisition Systems	
		4.5.1.1	Types of Detector	
			4.5.1.1.1	Direct vs Indirect Capture	
			4.5.1.1.2	Resolution	
			4.5.1.1.3	Radiation Exposure	
			4.5.1.1.4	Cost
	4.5.2	Market Analysis	
		4.5.2.1	France	
		4.5.2.2	Germany	
		4.5.2.3	United Kingdom	
		4.5.2.4	Scandinavian Countries	
		4.5.2.5	Countries of Southern / Western Europe	
		4.5.2.6	Countries of the Former Soviet Bloc	
		4.5.2.7	China	
		4.5.2.8	India	

		4.5.2.9	Japan	
		4.5.2.10	Australia/New Zealand	
		4.5.2.11	Rest of Asia	
	4.5.3	Product and Service Revenues	
		4.5.3.1	Europe	
			4.5.3.1.1	Suppliers Shares in Europe	
		4.5.3.2	Asia-Pacific	
			4.5.3.2.1	Supplier Shares in Asia-Pacific	

Exhibit 4-1: Mammography 
Exhibit 4-2: Reduction in Tumor Size: Screening Mammography Programs 
Exhibit 4-3: Insurance Reimbursement Programs in 2008
Exhibit 4-4: Mammography Process 
Exhibit 4-5: Selected Reimbursement Programs in Europe and Asia-Pacific 
Exhibit 4-6: Digital versus Analog Mammography Systems - Image Quality 
Exhibit 4-7: Digital Mammography Systems by Type of Detector 
Exhibit 4-8: Systems, Resolutions, and Radiation Levels in 2008 
Exhibit 4-9: Mammography Procedure Forecast by Region, 2008-2014 
Exhibit 4-10: Installed Base, Mammography Systems, 2008-2014 
Exhibit 4-11: Decrease in Mortality from U.K. Screening Program, 1995-2004 
Exhibit 4-12: Mammography Systems in Europe, Installed Base, 2008-2014 
Exhibit 4-13: Mammography Systems in Europe, Unit Forecast, 2008-2014 
Exhibit 4-14: Analogue Sales Forecast in Europe, 2008-2014 
Exhibit 4-15: CR Device Sales Forecast in Europe, 2008-2014
Exhibit 4-16: FFD Device Sales Forecast in Europe, 2008-2014 
Exhibit 4-17: Mammography System Sales in Europe, 2008-2014 
Exhibit 4-18: Supplier Shares in Europe, 2008 
Exhibit 4-19: Mammography Systems, Asia-Pacific, Installed Base, 2008-2014 
Exhibit 4-20: Mammography Systems, Asia-Pacific, Unit Forecast, 2008-2014 
Exhibit 4-21: Analogue Sales Forecast in Asia-Pacific, 2008-2014 
Exhibit 4-22: CR Device Sales Forecast in Asia-Pacific, 2008-2014 
Exhibit 4-23: FFD Device Sales in Asia-Pacific, 2008-2014 
Exhibit 4-24: Mammography System Sales in Asia-Pacific, 2008-2014 
Exhibit 4-25: Supplier Shares in Asia-Pacific, 2008	

5.	ULTRASOUND	
5.1	International Markets for Breast Ultrasound Products	
	5.1.1	Product Types	
5.2	The Procedure	
	5.2.1	Screening	
	5.2.2	Guided Biopsy	
	5.2.3	Wire Location	
5.3	Additional Capabilities	
	5.3.1	Elastography
	5.3.2	CAD	
	5.3.3	Image Fusion	
5.4	Regional Procedure & Market Forecasts	
	5.4.1	Europe	
		5.4.1.1	France, Germany, the U.K., and Other Countries in Northern/Western Europe	
		5.4.1.2	Scandinavian Countries	
		5.4.1.3	Southern/Western European Countries	
		5.4.1.4	Countries of the Former Soviet Bloc	
		5.4.1.5	Supplier Shares in Europe	
	5.4.2	Asia-Pacific	
		5.4.2.1	China	
		5.4.2.2	India	
		5.4.2.3	Japan	
		5.4.2.4	South Korea	
		5.4.2.5	Australia / New Zealand	
		5.4.2.6	Rest of Asia	
		5.4.2.7	Supplier Shares in Asia-Pacific	

Exhibit 5-1: Ultrasound Procedures 
Exhibit 5-2: Mammography & Ultrasound, Dense & Fatty-Replaced Breasts 
Exhibit 5-3: Breast Ultrasound Images 
Exhibit 5-4: Ultrasound in the Dense Breast 
Exhibit 5-5: Ultrasound Procedures Performed in Europe during 2008 
Exhibit 5-6: Ultrasound Procedure Forecast for Europe, 2008-2014 
Exhibit 5-7: Installed Base of Breast Ultrasound Systems in Europe, 2008-2014 
Exhibit 5-8: Ultrasound Units Sold in Europe, 2008-2014 
Exhibit 5-9: Breast Ultrasound Systems, European Sales Forecast, 2008-2014 
Exhibit 5-10: Breast Ultrasound Systems, Sales by Region in Europe, 2008-2014 
Exhibit 5-11: Supplier Shares in Europe, 2008 
Exhibit 5-12: Ultrasound Procedures Performed in Asia-Pacific during 2008 
Exhibit 5-13: Ultrasound Procedure Forecast for Asia-Pacific, 2008-2014 
Exhibit 5-14: Installed Base, Breast Ultrasound Systems in Asia-Pacific, 2008-2014 
Exhibit 5-15: Ultrasound Units Sold in Asia-Pacific, 2008-2014 
Exhibit 5-16: Breast Ultrasound Systems, Asia-Pacific Sales Forecast, 2008-2014 
Exhibit 5-17: Breast Ultrasound System Sales in Asia-Pacific, 2008-2014 
Exhibit 5-18: Supplier Shares in Asia-Pacific, 2008	

6.	CONTRAST-ENHANCED IMAGING PRODUCTS	
6.1	Magnetic Resonance Imaging	
	6.1.1	Clinical and Economic Challenges	
	6.1.1.1	Clinical Challenges	
	6.1.1.2	Economic Challenges	
	6.1.1.3	Other Factors	
6.2	Procedure & Market Forecasts for Europe	

	6.2.1	Supplier Shares	
6.3	Procedures & Market Forecasts, Asia-Pacific	
	6.3.1	Supplier Shares in the Asia-Pacific Region	
6.4	Breast Specific Gamma Imaging (BSGI)	

Exhibit 6-1: MRI Systems per Million Inhabitants in Europe, 2008-2014
Exhibit 6-2: European Procedure Forecast, 2008-2014 
Exhibit 6-3: MRI Systems, European Unit Forecast, 2008-2014 
Exhibit 6-4: European Sales Forecast, Breast-Enabled MRI Products, 2008-2014 
Exhibit 6-5: Supplier Shares in Europe, 2008 
Exhibit 6-6: MRI Systems per Million Inhabitants, Asia-Pacific Region, 2008-2014 
Exhibit 6-7: Procedure Forecast for the Asia-Pacific Region, 2008-2014 
Exhibit 6-8: MRI Systems, Unit Forecast for the Asia-Pacific Region, 2008-2014 
Exhibit 6-9: Sales Forecast in Asia-Pacific, Breast-Enabled MRI, 2008-2014 
Exhibit 6-10: Sales Forecast in Asia-Pacific (Excl. China and India), 2008-2014 
Exhibit 6-11: Supplier Shares in the Asia-Pacific Region, 2008	

7.	INTERVENTIONAL PROCEDURES & PRODUCTS	
7.1	Biopsy	
	7.1.1	Clinical Results	
	7.1.2	Histopathology	
	7.1.3	Cytopathology	
	7.1.4	Biopsy Methods	
		7.1.4.1	Spring-Loaded Core Needle Biopsy	
		7.1.4.2	Vacuum-Assisted Biopsy	
			7.1.4.2.1	Selected Devices	
		7.1.4.3	Fine Needle Aspiration	
	7.1.5	Biopsy Marking Devices	
7.2	Alternatives to Biopsy: Breast-Specific Antigens	
7.3	Brachytherapy	
7.4	Procedure Forecasts and Market Analyses	
	7.4.1	Vacuum-Assisted Biopsy	
	7.4.2	Spring-Loaded Core Needle Biopsy	
	7.4.3	Brachytherapy	
	7.4.4	European Analysis	
		7.4.4.1	France, Germany, the U.K., and Other	
		7.4.4.2	Scandinavian Countries	
		7.4.4.3	Countries in Southern / Western Europe	
		7.4.4.4	Countries of the Former Soviet Bloc	
	7.4.5	Asia-Pacific	
	7.4.6	Product Sales in the European Region	
		7.4.6.1	Vacuum Assisted Biopsy Products	
			7.4.6.1.1	Supplier Shares	
		7.4.6.2	Spring-Loaded Biopsy Devices	
	7.4.7	Product Sales in the Asia-Pacific Region	
		7.4.7.1	Vacuum-Assisted Biopsy Products	
			7.4.7.1.1	Supplier Shares	
		7.4.7.2	Spring-Loaded Biopsy Devices	

Exhibit 7-1: Core Needle Biopsy Devices 
Exhibit 7-2: Relative Volumes of Biopsy Device Specimens 
Exhibit 7-3: Vacuum-Assisted Biopsy Procedure Forecast in Europe, 2008-2014 
Exhibit 7-4: Vacuum-Assisted Biopsy Procedure Forecast, Asia-Pacific, 2008-2014 
Exhibit 7-5: Spring-Loaded Biopsy Procedure Forecast in Europe, 2008-2014 
Exhibit 7-6: Spring-Loaded Biopsy Procedure Forecast, Asia-Pacific, 2008-2014 
Exhibit 7-7: Installed Base, Vac.-Assisted Biopsy Devices in Europe, 2008-2014 
Exhibit 7-8: Vacuum-Assisted Biopsy Device Sales in Europe, 2008-2014 
Exhibit 7-9: Supplier Shares in Europe, 2008 
Exhibit 7-10: Spring-Loaded Biopsy Device Sales in Europe, 2008-2014 
Exhibit 7-11: Installed Vac.-Assisted Biopsy Systems in Asia-Pacific, 2008-2014 
Exhibit 7-12: Vac.-Assisted Biopsy Sales in the Asia-Pacific Region, 2008-2014 
Exhibit 7-13: Supplier Shares in the Asia-Pacific Region, 2008	

8.  COMPANY PROFILES	
8.1   Aloka	
8.2   Aurora Imaging Technology	
8.3   B-K Medical	
8.4   Carestream Health	
8.5   CR Bard	
8.6   Esaote	
8.7   FUJIFILM Medical Systems
8.8   General Electric
8.9   Hitachi	
8.10  Hologic 
8.11  i-CAD 
8.12  Johnson & Johnson (Ethicon Endosurgery and Ethicon) 
8.13  Mindray 
8.14  Philips Electric 
8.15  SenoRx 
8.16  Siemens 
8.17  Toshiba 


COMPANIES COVERED:

  1. Aloka
  2. Aurora Imaging Technology
  3. B-K Medical
  4. Carestream Health
  5. CR Bard
  6. Esaote
  7. FUJIFILM Medical Systems
  8. General Electric
  9. Hitachi
  10. Hologic
  11. i-CAD
  12. Johnson & Johnson (Ethicon Endosurgery and Ethicon)
  13. Mindray
  14. Philips Electric
  15. SenoRx
  16. Siemens
  17. Toshiba
Contact Us

Need help finding medtech research? Let us help you!